Attenuation of cocaine-induced locomotor activity by butyrylcholinesterase

Experimental and Clinical Psychopharmacology

Volumn 6, Issue 3, 1998, Pages 274-279

  Carmona, Gilberto N ^a,b   Schindler, Charles W ^a,b   Shoaib, Mohammed ^a,b   Jufer, Rebecca ^a,b   Cone, Edward J ^a,b   Goldberg, Steven R ^a,b   Greig, Nigel H ^a,c   Yu, Qian Sheng ^a,c   Gorelick, David A ^a,b  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

^b NATIONAL INSTITUTE ON DRUG ABUSE   (United States)

^c NATIONAL INSTITUTE ON AGING   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLINESTERASE; COCAINE;

ANIMAL MODEL; ARTICLE; BEHAVIOR; CONTROLLED STUDY; DRUG HALF LIFE; DRUG METABOLISM; ENZYME ACTIVITY; IN VITRO STUDY; INTRAPERITONEAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; LOCOMOTION; MALE; NONHUMAN; RAT;

EID: 0031822393     PISSN: 10641297     EISSN: None     Source Type: Journal    
DOI: 10.1037/1064-1297.6.3.274     Document Type: Article

References (21)

1. Broomfield, C. A., Maxwell, D. M., Solana, R. P., Castro, C. A., Finger, A. V., & Lenz, D. E. (1991). Protection by butyrylcholinesterase against organophosphorous poisoning in nonhuman primates. Journal of Pharmacology and Experimental Therapeutics, 259, 633-638.
2. Carmona, G. N., Baum, I., Schindler, C. W., Goldberg, S. R., Jufer, R., Cone, E., Slaughter, E., Belendiuk, G. W., & Gorelick, D. A. (1996). Plasma butyrylcholinesterase activity differs significantly in rhesus and squirrel monkeys. Life Sciences, 59, 939-943.
3. Carrera, M. R. A., Ashley, J. A., Parsons, L. H., Wirsching, P., Koob, G. F., & Janda, K. D. (1995). Suppression of psychoactive effects of cocaine by active immunization. Nature, 378, 727-730.
4. Erzouki, H. K., Baum, I., Goldberg, S. R., & Schindler, C. W. (1993). Comparison of the effects of cocaine and its metabolites on cardiovascular function in anesthetized rats. Journal of Cardiovascular Pharmacology, 22, 557-563.
5. Fox, B. S., Kantak, K. M., Edwards, M. A., Black, K. M., Bollinger, B. K., Botka, A. J., French, T. L., Thompson, T. L., Schad, V. C., Greenstein, J. L., Gefter, M. L., Exley, M. A., Swain, P. A., & Briner, T. J. (1996). Efficacy of a therapeutic cocaine vaccine in rodent models. Nature Medicine, 2, 1129-1132.
6. Genovese, R. F., & Doctor, B. P. (1995). Behavioral and pharmacological assessment of butyrylcholinesterase in rats. Pharmacology Biochemistry and Behavior, 51, 647-654.
7. Gorelick, D. A. (1997). Enhancing cocaine metabolism with butyrylcholinesterase as a treatment strategy. Drug and Alcohol Dependence, 48, 159-165.
8. Greig, N. H., Pei, X. F., Soncrant, T. T., Ingram, D. K., & Brossi, A. (1995). Phenserine and ring C hetero-analogues: Drug candidates for the treatment of Alzheimer's disease. Medicinal Research Review, 15, 3-31.
9. Hoffman, R. S., Morasco, R., & Goldfrank, L. R. (1996). Administration of purified human plasma cholinesterase protects against cocaine toxicity in mice. Journal of Toxicology and Clinical Toxicology, 34, 259-266.
10. Klose, R., & Gutensohn, G. (1976). Behandlung einer Alkylphosphatintoxikation mit gereiniger Serumcholinesterase. Praktische Anaesthesie, 11, 1-7.
11. Konkol, R. J., Erickson, B. A., Doerr, J. K., Hoffman, R. G., & Madden, J. A. (1992). Seizures induced by the cocaine metabolite benzoylecgonine in rats. Epilepsia, 33, 420-427.
12. Landry, D. W., Zhao, K., Yang, G. X.-Q., Glickman, M., & Georgiadis, T. M. (1993). Antibody-catalyzed degradation of cocaine. Science, 259, 1899-1901.
13. Lynch, T. J., Mattes, C. E., Singh, A., Bradley, R. M., Brady, R. O., & Dretchen, K. L. (1997). Cocaine detoxification by human plasma butyrylcholinesterase. Toxicology and Applied Pharmacology, 145, 363-371.
14. Madden, J. A., & Powers, R. H. (1990). Effect of cocaine and cocaine metabolites on cerebral arteries in vitro. Life Sciences, 47, 1109-1114.
15. Mattes, C., Bradley, R., Slaughter, E., & Browne, S. (1996). Cocaine and butyrylcholinesterase (BChE): Determination of enzymatic parameters. Life Sciences, 13, 257-261.
16. H)-benzoylnorecgonine in the brain of rats. Life Sciences, 19, 1585-1596.
17. Raveh, L., Grunwald, J., Marcus, D., Papier, Y., Cohen, E., & Ashani, Y. (1993). Human butyrylcholinesterase as a general prophylactic for nerve agent toxicity. Biochemical Pharmacology, 45, 2465-2474.
18. Schindler, C. W., Carmona, G. N., Goldberg, S. R., Greig, N. H., Cone, E. J., Shoaib, M., Preston, K., & Gorelick, D. A. (1996). Influence of butyrylcholinesterase (BChE) on cocaine-induced motor activity in rats. Society for Neuroscience Abstracts, 22, 1930.
19. Shoaib, M., Shippenberg, T. S., Goldberg, S. R., & Schindler, C. W. (1995). Behavioral studies with the glycine partial agonist (+)-HA966 on cocaine-induced locomotor activity and reinforcement. Behavioral Pharmacology, 6, 568-576.
20. Stewart, D. J., Inaba, T., Tang, B. K., & Kalow, W. (1977). Hydrolysis of cocaine in human plasma by cholinesterase. Life Sciences, 20, 1557-1563.
21. Yang, G., Chun, J., Arakawa-Uramoto, H., Wang, X., Gawinowicz, M. A., Zhao, K., & Landry, D. W. (1996). Anti-cocaine catalyticantibodies: A synthetic approach to improved antibody diversity. Journal of the American Chemical Society, 118, 5881-5890.